Samsung Biologics Reports Q3 Operating Profit of 56.5 Billion KRW, Up 139% Year-on-Year

[Asia Economy Reporter Minji Lee] Samsung Biologics announced on the 21st that its operating profit for the third quarter reached 56.534 billion KRW. This represents a 139% increase compared to the same period last year. Sales increased by 48% to 274.5 billion KRW, and net profit reached 56 billion KRW, marking a 27% increase.